Alembic Pharma’s arm enters into JV deal with Adwiya Mami

27 Oct 2014 Evaluate

Alembic Pharmaceuticals’ 100% subsidiary Alembic Global Holding has entered into  joint venture (JV) deal with Adwiya Mami SARL Algeria. The deal envisages investment by AGH to the extent of 49% equity of Adwiya Mami. Post conclusion of deal the company will be renames as Alembic Mami SPA.

Adwiya Mami owns a state of art formulation plant with a capacity of 1.2 billion per annum oral solids. The plant has been designed and developed by a leading European Pharmaceutical company in line with the cGMP requirements. The plant has enough headroom for future expansion. The investment in Adwiya Mami will give AGH a quick entry to the attractive Algerian market.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×